Part I Item 1A. Risk Factors and elsewhere in this Annual Report on Form 10-K. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. This Annual Report on Form 10-K also contains estimates, projections and other information concerning our industry, our business, and the market...
Q2 FY2026 — expected 2026-08-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126192 | EDGAR | 100K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-046125 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0000950170-24-030767 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0000950170-23-010921 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005194 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012514 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-010998 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001564590-19-007805 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001564590-18-007402 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280174 | EDGAR | 68K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107388 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070380 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127016 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0000950170-24-090782 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060400 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000950170-23-062897 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041314 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021187 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0000950170-22-024971 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016443 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0000950170-22-010064 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001193125-26-126244 | EDGAR | 3K words |
| 2026-01-30 | 0001193125-26-032004 | EDGAR | — |
| 2025-12-19 | 0001193125-25-325821 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280518 | EDGAR | — |
| 2025-08-12 | 0001193125-25-178970 | EDGAR | — |
| 2025-06-18 | 0001193125-25-142807 | EDGAR | — |
| 2025-05-28 | 0001193125-25-128680 | EDGAR | — |
| 2025-05-13 | 0001193125-25-118882 | EDGAR | — |
| 2025-04-28 | 0001193125-25-100433 | EDGAR | — |
| 2025-03-27 | 0001193125-25-065633 | EDGAR | — |
167 total filings indexed. 136 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001701108 |
| Ticker | SPRO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.sperotherapeutics.com |
| Listed | 2017-11-02 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report